Human African trypanosomiasis (HAT), also known as sleeping sickness, is a rare disease today, but throughout the 20th century it has demonstrated its potential for devastating epidemics. Over the last twenty years, substantial efforts against HAT enabled to dramatically reduce its prevalence, and the disease is now targeted for elimination...

Background: Diminazene diaceturate (DA) and isometamidium chloride hydrochloride (ISM) are with homidium bromide, the main molecules used to treat African Animal Trypanosomosis (AAT). These drugs can be purchased from official suppliers but also from unofficial sources like local food markets or street vendors. The sub-standard quality of some of these...

With the intent of aiding efforts towards the elimination of the human African trypanosomiasis (HAT), also known as sleeping sickness, FAO and WHO jointly held a training course for Eastern and Southern African countries. The training was aimed at country level health experts, and focused on the utilization of the...

The stakeholders workshop was organized by FAO and the Tsetse and Trypanosomosis Control Unit in Mali (CCLMT, Cellule de Coordination de Lutte contre les Mouches Tsé-tsé et les trypanosomoses animales, Direction Nationale des Services Vétérinaires, Ministère de l’Elevage et de la Pêche). Nineteen (19) participated, including the technical adviser of...

Trypanosoma brucei gambiense causes human African trypanosomiasis (HAT). Between 1990 and 2015, almost 440 000 cases were reported. Large-scale screening of populations at risk, drug donations, and efforts by national and international stakeholders have brought the epidemic under control with gambiense-HAT elimination as a public health problem for 2020, and...